Salbutamol to Levosalbutamol Dose Conversion
Levosalbutamol should be administered at half the milligram dose of racemic salbutamol to achieve equivalent bronchodilation. 1
Conversion Ratios by Formulation
Nebulized Solutions
For children:
- Salbutamol: 0.15 mg/kg (minimum 2.5 mg) converts to Levosalbutamol: 0.075 mg/kg (minimum 1.25 mg) 1, 2
- This 2:1 conversion ratio applies across all pediatric dosing scenarios 1
For adults:
- Salbutamol: 2.5-5 mg converts to Levosalbutamol: 1.25-2.5 mg 1, 3
- Standard adult salbutamol dose of 5 mg equals levosalbutamol 2.5 mg 3
Metered-Dose Inhalers (MDI)
The conversion ratio is also 2:1 for MDI formulations:
- Salbutamol MDI: 90 mcg/puff converts to Levosalbutamol MDI: 45 mcg/puff 1
- For acute exacerbations: 4-8 puffs of either formulation every 20 minutes for 3 doses, then every 1-4 hours as needed 1, 2
Pharmacologic Basis for Conversion
The 2:1 ratio exists because racemic salbutamol contains equal amounts of R-enantiomer (active levosalbutamol) and S-enantiomer (therapeutically inactive). 4, 5
- Beta2-agonist activity resides almost exclusively in the R-enantiomer 4
- Clinical studies demonstrate that 100 mcg levosalbutamol produces equivalent bronchodilation to 200 mcg racemic salbutamol 6
- The relative dose potency has been confirmed as approximately 2:1 across multiple formulations 1, 5
Acute Exacerbation Dosing Schedules
Initial treatment protocol (both formulations):
- Administer every 20 minutes for 3 doses 1, 2, 7
- Then adjust to every 1-4 hours based on severity and clinical response 1, 2
For severe exacerbations:
- Consider hourly or continuous nebulization 1, 7
- Add ipratropium bromide (0.25-0.5 mg for children, 500 mcg for adults) to enhance bronchodilation 1, 2, 3
Administration Technique Considerations
Proper dilution is essential for optimal drug delivery:
- Dilute nebulizer solutions to a minimum of 3-4 mL with normal saline 2, 3
- Use gas flow of 6-8 L/min for nebulization 1, 2
- Continue nebulization until approximately one minute after "spluttering" occurs (typically 5-10 minutes) 3
Clinical Equivalence and Safety
Levosalbutamol at half the dose demonstrates equivalent or slightly superior efficacy compared to racemic salbutamol: 1, 8
- One pediatric study showed levosalbutamol produced better improvement in respiratory rate (24.4 vs 27.6/min), heart rate (115.5 vs 124.5/min), and oxygen saturation (97.2% vs 95.0%) compared to racemic salbutamol 8
- Racemic salbutamol causes more tachycardia due to the S-enantiomer 8
- However, well-designed clinical studies have not found significant toxicity from S-salbutamol in racemic formulations 4
Common Pitfalls to Avoid
Do not use equal milligram doses of levosalbutamol and salbutamol - this would result in double the intended beta-agonist effect and increased adverse effects 1, 2
Always use minimum doses even when weight-based calculations suggest lower amounts:
- Children: minimum 1.25 mg levosalbutamol (vs 2.5 mg salbutamol) 1, 2
- Adults: minimum 1.25 mg levosalbutamol (vs 2.5 mg salbutamol) 1, 3
Monitor for adverse effects with both formulations: